| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |